These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study. Kluge M; Schuld A; Himmerich H; Dalal M; Schacht A; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T J Clin Psychopharmacol; 2007 Dec; 27(6):662-6. PubMed ID: 18004133 [TBL] [Abstract][Full Text] [Related]
9. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268 [TBL] [Abstract][Full Text] [Related]
11. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia. Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413 [TBL] [Abstract][Full Text] [Related]
12. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study. Conley RR; Kelly DL; Richardson CM; Tamminga CA; Carpenter WT J Clin Psychopharmacol; 2003 Dec; 23(6):668-71. PubMed ID: 14624201 [No Abstract] [Full Text] [Related]
14. Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study. Kinon BJ; Volavka J; Stauffer V; Edwards SE; Liu-Seifert H; Chen L; Adams DH; Lindenmayer JP; McEvoy JP; Buckley PF; Lieberman JA; Meltzer HY; Wilson DR; Citrome L J Clin Psychopharmacol; 2008 Aug; 28(4):392-400. PubMed ID: 18626265 [TBL] [Abstract][Full Text] [Related]
15. Switching clozapine responders to olanzapine. Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595 [TBL] [Abstract][Full Text] [Related]
16. Switching from clozapine to olanzapine in treatment-refractory schizophrenia: safety, clinical efficacy, and predictors of response. Henderson DC; Nasrallah RA; Goff DC J Clin Psychiatry; 1998 Nov; 59(11):585-8. PubMed ID: 9862604 [TBL] [Abstract][Full Text] [Related]
17. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036 [TBL] [Abstract][Full Text] [Related]
18. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone. Still DJ; Dorson PG; Crismon ML; Pousson C Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479 [TBL] [Abstract][Full Text] [Related]
19. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Naber D; Riedel M; Klimke A; Vorbach EU; Lambert M; Kühn KU; Bender S; Bandelow B; Lemmer W; Moritz S; Dittmann RW Acta Psychiatr Scand; 2005 Feb; 111(2):106-15. PubMed ID: 15667429 [TBL] [Abstract][Full Text] [Related]
20. Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. Chengappa KN; Pollock BG; Parepally H; Levine J; Kirshner MA; Brar JS; Zoretich RA J Clin Psychopharmacol; 2000 Jun; 20(3):311-6. PubMed ID: 10831017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]